This section of the website is for patients who have been prescribed Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) in the UK. Information for members of the general public can be found here.

This website has been commissioned by Ipsen UK and is intended for a UK audience.

Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.

All materials

Information booklet for patients with cervical dystonia receiving Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex)

Cervical Dystonia File
19 pages

A downloadable information booklet for patients with cervical dystonia receiving Dysport®.

DYS-UK010673 | August 2026

Information booklet for patients with cervical dystonia receiving Dysport<sup>®</sup> (<em>Clostridium botulinum</em> type A toxin-haemagglutinin complex)
Explore more Cervical Dystonia Patient Support

Explore more Cervical Dystonia Patient Support

Browse

To access relevant information about Cervical Dystonia, please confirm the following:

Adverse events should be reported.
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 
01753 627777.

I am a patient

This section provides information to support patients that have been prescribed Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex).

I am a patient

I am a member of the general public

This section is for members of the general public.

I am a member of the general public

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.